GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (STU:1OA) » Definitions » EV-to-Revenue

Blueberries Medical (STU:1OA) EV-to-Revenue : 24.22 (As of Apr. 27, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Blueberries Medical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Blueberries Medical's enterprise value is €4.77 Mil. Blueberries Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was €0.20 Mil. Therefore, Blueberries Medical's EV-to-Revenue for today is 24.22.

The historical rank and industry rank for Blueberries Medical's EV-to-Revenue or its related term are showing as below:

STU:1OA' s EV-to-Revenue Range Over the Past 10 Years
Min: 9.66   Med: 26.55   Max: 83.18
Current: 24.54

During the past 10 years, the highest EV-to-Revenue of Blueberries Medical was 83.18. The lowest was 9.66. And the median was 26.55.

STU:1OA's EV-to-Revenue is ranked worse than
92.98% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs STU:1OA: 24.54

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-27), Blueberries Medical's stock price is €0.008. Blueberries Medical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €0.00. Therefore, Blueberries Medical's PS Ratio for today is .


Blueberries Medical EV-to-Revenue Historical Data

The historical data trend for Blueberries Medical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical EV-to-Revenue Chart

Blueberries Medical Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 209.94 83.18 18.25

Blueberries Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.61 18.25 21.41 13.22 22.69

Competitive Comparison of Blueberries Medical's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueberries Medical's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's EV-to-Revenue falls into.



Blueberries Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Blueberries Medical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4.772/0.197
=24.22

Blueberries Medical's current Enterprise Value is €4.77 Mil.
Blueberries Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueberries Medical  (STU:1OA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Blueberries Medical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.008/0
=

Blueberries Medical's share price for today is €0.008.
Blueberries Medical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueberries Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueberries Medical (STU:1OA) Business Description

Traded in Other Exchanges
Address
8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. It generates all of its revenues from Colombia.

Blueberries Medical (STU:1OA) Headlines

No Headlines